✨
AI Summary
- Annexon transitions to commercialization for GBS and GA treatments.
- Distinct strategies are planned for acute hospital vs. chronic ophthalmology markets.
- Two dedicated commercial teams will support upcoming product launches.
Guests on This Episode
DL
Doug Love
1 podcast appearance